PANTHERx Rare Pharmacy · 1 week ago
Pharmacy Billing Operations Specialist
PANTHERx Rare Pharmacy is the nation’s largest rare disease pharmacy, dedicated to providing exceptional patient care. The Pharmacy Billing Operations Specialist is responsible for billing and collecting assigned payer accounts, working closely with Pharmacy Benefit Managers and payers to ensure proper billing guidelines are followed.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Bills specialty pharmacy NCPDP (National Council for Prescription Drug Programs) claims
Makes collection calls and research on past due assigned accounts
Communicates with PBM for various rejections or overrides
Researches and processes refunds as required
Tracks denials trending
Prepares Bad Debt Write-Offs as required
Reconciles member accounts as needed
Handles multiple tasks and meets deadlines
Other duties as assigned within scope of practice
Qualification
Required
Bachelor's degree in business or related field required. Equivalent work experience may substitute education requirements
Detailed understanding of Pharmacy billing/collections practices with all payer types
Excellent oral and written communication skills communicating effectively with all levels of management
Strong problem-solving skills to evaluate all aspects of a problem or opportunity and draw valid conclusions to make appropriate and timely decisions
Consistently uses tact, sensitivity, sound judgement, and a professional attitude
Knowledge of Microsoft Office Suite, especially Excel, Outlook, and PowerPoint
Preferred
2 years of pharmacy billing/collections knowledge in a specialty pharmacy setting
Benefits
Medical
Dental
Vision
Health savings and flexible spending accounts
401K with employer matching
Employer-paid life insurance
Short/long term disability coverage
Employee Assistance Program
Generous paid time off
Paid holidays
Company
PANTHERx Rare Pharmacy
PANTHERx Rare Pharmacy is the rare Disease Specialty Pharmacy'', servicing patients nationwide.
Funding
Current Stage
Late StageTotal Funding
unknown2020-12-15Acquired
Recent News
Morningstar.com
2026-01-09
2026-01-09
Company data provided by crunchbase